Point72 Asset Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $57.5M | Buy |
1,998,161
+1,219,763
| +157% | +$35.1M | 0.11% | 201 |
|
2025
Q1 | $26.1M | Sell |
778,398
-2,010,541
| -72% | -$67.4M | 0.06% | 330 |
|
2024
Q4 | $143M | Buy |
2,788,939
+488,296
| +21% | +$25M | 0.31% | 58 |
|
2024
Q3 | $118M | Sell |
2,300,643
-480,213
| -17% | -$24.5M | 0.3% | 60 |
|
2024
Q2 | $125M | Sell |
2,780,856
-2,168,630
| -44% | -$97.1M | 0.33% | 65 |
|
2024
Q1 | $232M | Buy |
4,949,486
+1,532,586
| +45% | +$71.7M | 0.56% | 21 |
|
2023
Q4 | $122M | Sell |
3,416,900
-808,400
| -19% | -$28.8M | 0.29% | 60 |
|
2023
Q3 | $126M | Buy |
+4,225,300
| New | +$126M | 0.37% | 44 |
|
2023
Q2 | – | Sell |
-226,400
| Closed | -$3.64M | – | 1706 |
|
2023
Q1 | $3.64M | Sell |
226,400
-1,134,600
| -83% | -$18.2M | 0.01% | 723 |
|
2022
Q4 | $24.9M | Buy |
1,361,000
+50,800
| +4% | +$930K | 0.08% | 271 |
|
2022
Q3 | $25.7M | Sell |
1,310,200
-22,600
| -2% | -$444K | 0.1% | 252 |
|
2022
Q2 | $24.9M | Buy |
1,332,800
+126,462
| +10% | +$2.36M | 0.1% | 249 |
|
2022
Q1 | $26.5M | Buy |
1,206,338
+101,862
| +9% | +$2.24M | 0.11% | 235 |
|
2021
Q4 | $31.4M | Buy |
1,104,476
+654,676
| +146% | +$18.6M | 0.13% | 222 |
|
2021
Q3 | $9.47M | Sell |
449,800
-258,333
| -36% | -$5.44M | 0.04% | 472 |
|
2021
Q2 | $13.3M | Sell |
708,133
-566,867
| -44% | -$10.7M | 0.06% | 361 |
|
2021
Q1 | $19.5M | Buy |
1,275,000
+49,997
| +4% | +$764K | 0.09% | 262 |
|
2020
Q4 | $17.3M | Buy |
1,225,003
+713,015
| +139% | +$10.1M | 0.08% | 294 |
|
2020
Q3 | $8.02M | Buy |
511,988
+117,156
| +30% | +$1.84M | 0.04% | 427 |
|
2020
Q2 | $6.92M | Buy |
+394,832
| New | +$6.92M | 0.05% | 396 |
|
2020
Q1 | – | Sell |
-33,865
| Closed | -$850K | – | 785 |
|
2019
Q4 | $850K | Sell |
33,865
-98,135
| -74% | -$2.46M | ﹤0.01% | 693 |
|
2019
Q3 | $1.99M | Buy |
+132,000
| New | +$1.99M | 0.01% | 540 |
|